All Business Industries
Appointment Letter, dated as of July 27, 2021, of Mark Sabag
EX-10.25 4 d130792dex1025.htm EX-10.25 EX-10.25
Private and Confidential
July 27, 2021
To: Mark Sabag
Teva Global ID: 31507
Congratulations on your appointment as Executive Vice President, International Markets Commercial.
Effective Date: August 15, 2021
Your compensation will remain the same as prior to your appointment and the terms shall be as determined in your current employment agreement.
We strongly believe in the company and in your contribution to its success. We look forward to your continued commitment towards Tevas short and long-term strategic goals.
President and Chief Executive Officer
Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevia St., Tel Aviv ###-###-#### Israel | www.tevapharm.com